EDITORIAL article
Front. Pain Res.
Sec. Pharmacological Treatment of Pain
Volume 6 - 2025 | doi: 10.3389/fpain.2025.1662611
This article is part of the Research TopicInsight in Pharmacological Treatment of Pain – 2023View all 6 articles
Editorial: Insight in Pharmacological Treatment of Pain – 2023.
Provisionally accepted- 1Clinical Center, Pécs University, Pécs, Hungary
- 2Pecsi Tudomanyegyetem Klinikai Kozpont, Pécs, Hungary
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Pain symptoms and complaints can develop for no apparent reason, which can be explained by the disintegration of the pain modulatory system. In many cases, painful complaints are associated with depression in the older adults, and these patients visit the doctor with overlapping complaints and symptoms typical of chronic pain. It is very common for these patients to struggle with sleep disorders, compliance problems, selfesteem disorders, family conflicts, misunderstanding, distancing, aggression, anxiety, depression, or suicidal ideations. With the use of antidepressants, these signs and symptoms can improve quickly, which is why many antidepressants are used for pain relief. A co-administration of relatively novel sNRI atomoxetine used for attention deficit hyperactivity disorder (ADHD) and the anti-Parkinson pramipexole could be a new alternative way to treat chronic painful conditions, as Kasahara et al. demonstrated in their case report.Anticonvulsants are another type of agent effectively used in neuropathic pain, although their side effect profiles are suboptimal. It is especially exciting to read Ergisi and their group's narrative synthesis of research on the effect of topical gabapentin in patients with vulvodynia.Opioids are very effective analgesics; their efficacy has been proven in the treatment of severe or cancer pain. However, due to their poor side effect profile and potential for abuse, their routine use should be reconsidered. While cognitive disorders, frailty, and signs of deterioration predominate in the elderly, younger adults tend to struggle with existential issues, mid-life crises, and relationship problems. Chronic pain patients are prone to illicit opioid use or medication misuse with doctor-seeking behaviour. It can be challenging for practitioners to evaluate individual risk factors for opioid use disorders and avoid misuse of prescription opioids and prevent illicit opioid use. In the article published by Galán et al., we are provided with guidance indicating that Spanish pain specialists agree on the risk factors that can lead to opioid misuse.Any attempt to eliminate the use of opioids can be helpful in preventing side effects and improving the opioid crisis. Banik and their research group questioned the outcomes of human studies and investigated the effects of multimodal drug treatment and dexamethasone on surgical incisions in an animal model. It is heartwarming that this was studied with an opioid-free combination of analgesics and adjuvants. Their study can encourage clinicians to reevaluate their results in this field, which is, after all, one of the aims of translational medicine.One of the biggest burdens for the individual, the family, and the national economies is back pain. In an attempt to avoid surgery, interventions with anesthetics were regarded as a useful tool to clarify the diagnosis and treat the suspected structural damage. We now know that the effect of surgery and intervention is far below expectations. Spinal surgeries are currently performed only with a rather narrow indication, even in the case of obvious morphological abnormalities. Today, nonpharmacological and nonmedical therapies are the primary focus of pain specialists. Regular exercise, stretching, yoga, lifestyle changes, physical treatments, psychological approaches may help more to solve problems. Since pain is a multidimensional phenomenon, the evaluation and treatment of pain is also multimodal. The interventions used as part of multimodal analgesia provide a lot of help to the patient. It is difficult to estimate how many types of drugs and agents have been evaluated so far in spinal-pain research. In most cases, the underlying morphological problem does not correspond in a one-to-one manner with the severity of pain experienced. Despite this, the number of spinal interventions is not decreasing, indicating the efforts of pain specialists to help their patients. Corticosteroids relieve pain and inflammation; therefore, these agents are included in the palette of pain medicine providers. The effectiveness of corticosteroid injections is difficult to prove with well-designed studies because patients are heterogeneous in terms of demographics, morphology and psychosocial background. Moreover, pain specialists use various types of steroids, at different concentrations and in different volumes, employing a range of methodologies. Considering one of the features of corticosteroids-whether they are particulate or nonparticulate-certain techniques, such as transforaminal injection, pose risks. In regional anesthesia practice, dexamethasone is regarded as an effective adjuvant that extends the duration of action of local anesthetics in patients undergoing peripheral nerve blockade. Antibiotics, analgesics, adjuvants, and contrast materials are also included in the armamentarium of pain clinicians' daily practice. The interventions are often performed in patients with other health conditions that require some form of pharmacotherapy. The possible interactions should not only be considered, but also discussed with patients. The plethora of agents used in the context of spinal intervention is provided in the review by Torralba et al.In this topic, pharmacotherapy stands as an indispensable ally that empowers clinicians to deliver individualized relief and improve the quality of life of those burdened by pain.
Keywords: Elderly Pain Management, Spinal pain, vulvodynia treatment, Adjuvant pain medications, Opioid misuse, Multimodal Pain Management, Pain pharmacological treatment
Received: 09 Jul 2025; Accepted: 17 Jul 2025.
Copyright: © 2025 Almasi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Robert Gyula Almasi, Clinical Center, Pécs University, Pécs, Hungary
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.